Education
About Us
Working with TipRanks
Follow Us
Cardinal Health (CAH)
NYSE:CAH
Earnings Data
Report Date
Apr 30, 2026Before Open (Confirmed)
Period Ending
2026 (Q3)Consensus EPS Forecast
2.78Last Year’s EPS
2.35Same Quarter Last Year
Strong Buy
Based on 14 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call communicated broad-based, strong operational and financial performance across segments with multiple upward guidance revisions (notably EPS and pharma profit), robust revenue and profit growth, and improved leverage and cash generation. Most negatives were transitory or tied to known acquisition and macro headwinds (interest costs, tariffs, timing-related GNPD inventory effects) that management is actively addressing. Given the weight and scale of positive results, guidance raises, and clear momentum in specialty and other growth businesses, positives substantially outweigh the negatives.Company Guidance
Raised Full-Year EPS Guidance
Updated fiscal 2026 non-GAAP diluted EPS guidance to $10.15–$10.35 (was at least $10), implying year-over-year EPS growth of ~23%–26% driven by strong Q1/Q2 performance and improved outlook for the remainder of the year.
Strong Consolidated Revenue and Profit Growth
Second-quarter consolidated revenue increased 19% year-over-year to $66.0 billion; operating earnings rose 38% to $877 million; non-GAAP diluted EPS was $2.63, up 36% from $1.93 a year ago.
Robust Gross Margin and Disciplined Cost Management
Gross margin increased 24% to $2.4 billion. SG&A increased 16% to $1.5 billion, but organic SG&A growth (ex-acquisitions) was low-single-digits and GNPD saw lower SG&A year-over-year due to optimization efforts.
Pharmaceutical & Specialty Segment Leadership
Pharma & Specialty revenue rose 19% to $61.0 billion; segment profit grew 29% to $687 million. GLP-1 sales contributed ~6 percentage points of revenue growth. Company expects specialty revenues to surpass $50 billion in fiscal 2026 and cites strong generic unit growth and MSO contributions (Solaris Health acquisition closed in November).
Other Growth Businesses Outperformance (Nuclear, At‑Home, Optifreight)
Other segment revenue increased 34% to $1.7 billion; segment profit up 52% to $179 million. Theranostics revenue growth exceeded 30%; Optifreight and At-Home Solutions each grew revenues by over ~30%, with ADS acquisition integrating well.
GNPD Turnaround Momentum
GNPD revenue increased 3% to $3.3 billion and segment profit rose to $37 million from $18 million a year ago, with U.S. Cardinal Health brand revenue up 10% driven by operational improvements and supply-chain/simplification initiatives.
Strong Cash Generation and Capital Return
Year-to-date adjusted free cash flow of $1.8 billion and expected FY adjusted free cash flow of $3.0–$3.5 billion. Ended quarter with $2.8 billion cash, YTD capex of ~$240 million, returned $1.0 billion to shareholders (≈$250M dividends + $750M repurchases), and completed $375M repurchase in Q2 (weighted avg price $173).
Balance Sheet / Leverage Improvement
Moody’s adjusted leverage ratio improved to 3.2x, back within the company target range of 2.75x–3.25x, providing flexibility for opportunistic capital deployment.
Operational & Service Improvements
Investments in technology and footprint drove a 10% improvement in service levels over the past two years; Vantas HQ e‑commerce and other tech investments highlighted as contributors to efficiency and margin profile.
CAH Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
CAH Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Feb 05, 2026 | $206.85 | $227.18 | +9.83% |
Oct 30, 2025 | $164.06 | $189.37 | +15.43% |
Aug 12, 2025 | $156.76 | $145.46 | -7.21% |
May 01, 2025 | $140.05 | $144.26 | +3.00% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Cardinal Health (CAH) report earnings?
Cardinal Health (CAH) is schdueled to report earning on Apr 30, 2026, Before Open (Confirmed).
What is Cardinal Health (CAH) earnings time?
Cardinal Health (CAH) earnings time is at Apr 30, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is CAH EPS forecast?
CAH EPS forecast for the fiscal quarter 2026 (Q3) is 2.78.
